España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Icecure Medical
ICCM
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.820000
-0.01
-1.20%
At Close: -
$0.837700
0.02
2.16%
After Hours: 4:58 PM EDT
15 minutes delayed
Get Report
Comment
Icecure Medical (ICCM) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Icecure Medical (NASDAQ:ICCM) Stock
Icecure Medical Stock (NASDAQ: ICCM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 22, 2024
IceCure Medical Presents Key Findings On ProS...
Benzinga Newsdesk
Friday, July 19, 2024
IceCure Medical Receives Receipt From Nasdaq ...
Benzinga Newsdesk
Tuesday, July 09, 2024
IceCure Medical Announces Independent Study R...
Benzinga Newsdesk
Tuesday, July 02, 2024
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Monday, July 01, 2024
U.S. FDA Grants Regulatory Clearance To IceCu...
Benzinga Newsdesk
Monday, June 17, 2024
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, June 12, 2024
IceCure Medical Reports Data From Its Kidney ...
Benzinga Newsdesk
Wednesday, June 05, 2024
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Tuesday, June 04, 2024
IceCure Medical Announces FDA Advisory Panel ...
Benzinga Newsdesk
Wednesday, May 29, 2024
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Tuesday, May 28, 2024
Icecure Medical Q1 EPS $(0.08), Inline, Sales...
Benzinga Newsdesk
Wednesday, May 15, 2024
The Oncology Institute, Inc. Reports Q1 Loss, Lags Revenue Estimates
Zacks
Tuesday, May 07, 2024
IceCure Is Expected To Receive A Total Of $13...
Benzinga Newsdesk
Independent Study Results In Japan Demonstrat...
Benzinga Newsdesk
Tuesday, April 16, 2024
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Monday, April 15, 2024
IceCure Medical Reports Final ICE3 Breast Can...
Benzinga Newsdesk
Thursday, April 04, 2024
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Icecure Medical Q4 EPS $(0.07), Inline, Sales...
Benzinga Newsdesk
Wednesday, April 03, 2024
As Of March 31, 2024, IceCure Medical Had Cas...
Benzinga Newsdesk
Icecure Medical FY EPS $(0.32), Inline, Sales...
Benzinga Newsdesk
Earnings Scheduled For April 3, 2024
Benzinga Insights
Tuesday, April 02, 2024
IceCure Submits 510(k) With FDA For Clearance...
Benzinga Newsdesk
Wednesday, March 20, 2024
Alliance Global Partners Maintains Buy on Ice...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Tuesday, March 19, 2024
IceCure Medical Reports Topline Results From ...
Benzinga Newsdesk
Tuesday, March 12, 2024
IceCure Receives Notice Of Patent Allowance I...
Benzinga Newsdesk
Tuesday, March 05, 2024
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Monday, March 04, 2024
IceCure's ProSense Alternative Treatment For ...
Benzinga Newsdesk
Monday, February 26, 2024
Study Using IceCure's ProSense Treatment Resu...
Benzinga Newsdesk
Tuesday, January 30, 2024
Market-Moving News for January 30th
Benzinga Newsdesk
U.S. FDA Grants IceCure Medical's Appeal, Reo...
Benzinga Newsdesk
Friday, January 12, 2024
IceCure Medical Regains Compliance With Nasda...
Benzinga Newsdesk
Wednesday, January 10, 2024
IceCure Medical Says 2023 Revenues On a Preli...
Benzinga Newsdesk
Wednesday, January 03, 2024
New Study Reports IceCure's ProSense Boosts I...
Benzinga Newsdesk
IceCure's Announces Publication Of Study Titl...
Benzinga Newsdesk
Wednesday, December 13, 2023
IceCure's Medical's Study Using ProSense Find...
Benzinga Newsdesk
Wednesday, November 29, 2023
IceCure's ProSense Deepens Regulatory Approva...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Tuesday, November 28, 2023
Crude Oil Surges 2%; Tharimmune Shares Plummet
Lisa Levin
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
What's Going On With IceCure Medical Ltd Stock?
Erica Kollmann
IceCure Medical shares are trading higher aft...
Benzinga Newsdesk
Market-Moving News for November 28th
Benzinga Newsdesk
IceCure Medical Announces Release Of A Study ...
Benzinga Newsdesk
Wednesday, November 15, 2023
IceCure Medical Reports 9-Month GAAP EPS $(0....
Benzinga Newsdesk
IceCure Medical Appeals with US FDA for a Re...
Benzinga Newsdesk
Friday, November 03, 2023
IceCure Medical Announces Receipt Of Nasdaq M...
Benzinga Newsdesk
Monday, October 30, 2023
IceCure's ICE3 Trial Results Demonstrating 96...
Benzinga Newsdesk
Monday, October 09, 2023
Why Avidity Biosciences Shares Are Trading Higher By Around 9%: 20 Stocks Moving Premarket
Lisa Levin
Thursday, October 05, 2023
Women Deemed Inoperable For Breast Cancer Ben...
Benzinga Newsdesk
Show More